AVIA Names John Fiacco as Chief Growth Officer

Dotmatics collaborates with LabVoice to enable voice-assisted laboratory workflows

Dyadic C1 protein expression platform explored in fight against COVID-19

JUPITER, FL, UNITED STATES - Oct 30, 2020 - Dyadic International, Inc. (NASDAQ: DYAI) a leading biotechnology innovator focused on accelerating the development and lowering the manufacturing costs of vaccines and biopharmaceuticals, recently announced results which further support record expression levels of the SARS-CoV-2 Receptor Binding Domain (RBD) antigen produced from Dyadic’s industrially proven proprietary & patented hyper-productive C1 gene expression platform

Muscular Dystrophy Association Launches MOVR Visualization and Reporting Platform to Improve Patient Care and Accelerate Drug Discovery

NEW YORK, NY, UNITED STATES - Oct 29, 2020 - The Muscular Dystrophy Association (MDA) announced today the launch of the neuroMuscular ObserVational Research (MOVR) Visualization and Reporting Platform (VRP)

Plus Therapeutics Announces Initiation of Final Cohort of ReSPECT™ Glioblastoma Trial

AUSTIN, TX - Oct 29, 2020 - Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that it has treated the first patient in the sixth and final cohort of its National Cancer Institute (NCI)-supported, multi-center ReSPECT™ Phase 1 dose-finding clinical trial evaluating Rhenium NanoLiposomes (RNL™) for the treatment of recurrent glioblastoma (GBM)

7th Crystal Structure Prediction Blind Test brings new challenges for computational chemists

CAMBRIDGE, UNITED KINGDOM - Oct 28, 2020 - Announcing the new challengeThis week the 7th CSP Blind Test begins - a major challenge in computational chemistry

OmniTier Streamlines Personalized Medicine Workflows with CompStor Insight™ for Next-Generation Sequencing Tertiary Analysis

MILPITAS, CA, UNITED STATES - Oct 27, 2020 - OmniTier Inc., an AI and multiomics application company whose bioinformatics solutions help deliver the promise of personalized medicine, debuted the CompStor Insight™ appliance for tertiary analysis in next-generation sequencing (NGS) applications

Vidence And 2bPrecise Announce Strategic Partnership To Unleash The Power Of Genomic Data In Precision Oncology

RALEIGH, NC, UNITED STATES - Oct 27, 2020 - Vidence, an oncology informatics company, has selected the 2bPrecise™ platform, a precision medicine data delivery solution, to make it easier for its Consortium Fellows to unlock the true power of genomic data at the point of care and facilitate the advancement of precision oncology

Baptist Health Engages Kyruus to Enable Next-Generation Online Patient Access Experience

BOSTON, MA, UNITED STATES - Oct 27, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that Baptist Health, the largest not-for-profit health system in Kentucky, has engaged the company to help elevate its digital access experience for consumers

Alfa Chemistry Offers Fluorinated Building Blocks for Material, Medicinal, Agricultural, Organic Chemistry Research

NY, NY - Oct 14, 2020 - The benefits of fluorochemistry to pharmaceutical applications are obvious and the past decades has seen increasing synthesis of fluorinated compounds in the preparation of new pharmaceuticals and agrochemicals

AI & Medicine Announces Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling for Drug Discovery

NY, NY, UNITED STATES - Oct 21, 2020 - AI & Medicine, one of the forerunners in the AI-assisted medicine area, announces it now provides PK/PD modeling service to help scientists and researchers more efficiently screen drugs and thus accelerating the process of new drug development

Protheragen Offers License Opportunities for Drug Development Programs

RONKONKOMA, NY - Oct 27, 2020 - Aiming to build a bridge between academics and industry, Protheragen, a company founded in Ronkonkoma, New York, 2009, announces to offer license opportunities for drug R&D companies

Scientific Knowledge Discovery Platform Pioneer, Eagle Genomics, Closes $9M in Scale-Up Funding as Major Brands Home in on the Microbiome Megatrend

CAMBRIDGE, UNITED KINGDOM - Oct 26, 2020 - Eagle Genomics, a pioneer in applying network science to biology – particularly linked to the microbiome – has closed $9 million in new scale-up funding

Shimmer Solicits Clinical Research Community Input on Expanded Open Wearables Initiative (OWEAR) Vision

CAMBRIDGE, MA - Oct 26, 2020 - Shimmer Research, a global leader in wearable technology for research applications, today announced that the Open Wearables Initiative (OWEAR) is evaluating a significant expansion of its vision and seeking industry input to build consensus

NCH Healthcare System Partners with eVideon to Enhance Digital Patient Engagement and Education

NEWTON, MI, UNITED STATES - Oct 26, 2020 - eVideon, a leader in interactive patient engagement and digital workflow solutions, today announced that NCH Healthcare System, one of the largest healthcare systems in Southwest Florida, will be implementing the company’s full suite of solutions in 576 patient rooms across its two hospitals

AVIA Names Linda Finkel as CEO

CHICAGO, IL, UNITED STATES - Oct 23, 2020 - AVIA, the nation’s leading digital transformation partner for healthcare organizations, announced that its board of directors has appointed AVIA President Linda Finkel to also serve as chief executive officer, effective November 1, 2020

BOC Sciences Lanuched A New Biotinylation Platform

SHIRLEY, NY, UNITED STATES - Oct 23, 2020 - Recently, BOC Sciences, a New York-based chemical and pharmaceutical supplier, announced to launch a new biotinylation technology platform for the scientific community

Profacgen Updated Its Pull Down Assay Service for Protein Interaction Study

SHIRLEY, NY, UNITED STATES - Oct 22, 2020 - Profacgen, with an organized team of scientists with extensive experience in the study of protein-protein interaction, recently updated its pull down assay service to help efficiently and specifically verify the predicted protein-protein interactions or identify novel interactions

Elsevier Signs Collaboration to Develop Novel Prediction Tool to Reduce Drug Development Safety Risk

LONDON, UNITED KINGDOM - Oct 22, 2020 - Elsevier, a global information analytics business specializing in science and health, today announced its collaboration with the pharmaceutical company Novartis to develop a safety margin risk assessment prediction tool, largely using PharmaPendium data

Aurinia Pharmaceuticals selects MyMeds&Me’s Reportum QuickStart platform to streamline drug safety reporting

LONDON, UK - Oct 21, 2020 - MyMeds&Me, a leading provider of drug safety software to transform the end-to-end pharmacovigilance process, have today announced that Aurinia Pharmaceuticals Inc